Chief Technology Officer
DM
Diasyst - Medication Intelligence
diasyst.com
Website unreachable since Oct 23, 2026
Diasyst provides medication intelligence solutions that empower healthcare providers to make timely and effective treatment decisions for diabetes and other chronic diseases. By addressing clinical inertia, Diasyst enhances patient outcomes and improves financial performance for healthcare systems.
- Artificial Intelligence
- Digital Health
- Healthcare Technology
- Software Only
Updated 23 months ago
Funding
Raised to date
$50KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
Healthcare providers often struggle to make timely and effective treatment decisions for patients with diabetes and other chronic diseases due to clinical inertia. This can lead to suboptimal patient outcomes and negatively impact the financial performance of healthcare systems.
Solution
Diasyst offers medication intelligence solutions designed to empower healthcare providers in managing diabetes and other chronic diseases. By providing timely and safe treatment decision support, Diasyst aims to eliminate clinical inertia, leading to improved patient outcomes and enhanced financial results for healthcare systems. The platform helps providers make quicker and more effective decisions, ultimately improving the quality of care and reducing healthcare costs associated with chronic disease management.
Target Audience
The primary target audience includes healthcare providers and healthcare systems focused on improving chronic disease management, specifically in diabetes care.
Features
- There is no information about product features on the website.